The trial, conducted across multiple international sites and involving 725 adults living with obesity or overweight but without type 2 diabetes, concluded in April 2026 after 76 weeks of treatment
JL-B: Methodology, Supervision, Writing review & editing
The pharmacokinetic profile also supported once-weekly dosing, and a reduction in body weight persisted up to day 43 after a single dose
Venn diagram analysis revealed eight consistent signals across all four algorithms: taste disorders, parosmia, allodynia, hypoglycemic unconsciousness, hypoglycemic seizure, hyperglycemic unconsciousness, vagus nerve disorder, and hyperglycemic seizure (Figs
Understanding oxidative stress and the role of antioxidants is vital for long-term health